Daiichi Sankyo's Enhertu Wins EU Approval for Early Breast Cancer Treatment
The EU approved Enhertu for adjuvant treatment of early breast cancer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The EU approved Enhertu for adjuvant treatment of early breast cancer.